from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3452/cut4

LFCtreatmentdescriptionclass of inhibitor

-0.597

Amikacinug/mL Amikacintranslation

0.989

Cap5-10ug/mL Capreomycintranslation

0.878

Rox10-50 ug/mL Roxithromycintranslation

-0.615

SM2-5 ug/mL Streptomycintranslation

0.623

Tet5-10 ug/mL Tetracyclinetranslation

-0.154

Rif0.2-5ug/mL Rifampicintranscription

0.138

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.099

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

3.027

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.329

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.348

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.625

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.608

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.960

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.109

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.616

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.073

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.389

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.009

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.306

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.979

KCN5-20 ug/mL Potassium cyaniderespiration

-0.137

NaN30.2-2 mM Sodium aziderespiration

1.028

Nigericin50 uM Nigericinrespiration

0.656

TRC10-150 ug/mL Triclosanrespiration

2.310

TRZ10-25 ug/mL Thioridazinerespiration

0.958

Valinomycin0.5-10 uM Valinomycinrespiration

-1.464

ZnSO42 mM ZnSO4respiration

0.172

menadione6-10 ug/mL Menadionerespiration

-0.017

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.505

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.143

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.432

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.775

NRP_1Non-replicating persistence stage 1dosRassociated

0.090

Amp0.2mg/mL AmpicillincellWall

0.333

Cephalexin20-100 ug/mL CephalexincellWall

-0.252

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.330

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.465

EMB10-20 ug/mL EthambutolcellWall

-0.402

Eta12-40 ug/mL EthionamidecellWall

-0.977

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.258

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.117

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.072

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.216

BZA0.12 mg/mL BenzamidearomaticAmides

0.151

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.753

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.695

H2O24 mM hydrogen peroxideDNAdamaging

-0.254

Levo10 ug/mL LevofloxacinDNAdamaging

-0.175

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.602

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.799

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.129

UVUV-irradiationDNAdamaging

1.101

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.639

Antimycin12.5-50 ug/mL Antimycin A?

0.410

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.215

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.469

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.912

PA8240.2-2 ug/mL PA-824?

1.156

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.106

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.337

Verapamil50 uM Verapamil?

0.258

mercaptoethanol2 mM 2-Mercaptoethanol?

0.029

methoxatin10-20 ug/mL Methoxatin?